Epidermal growth factor receptor
Epidermal growth factor receptor
About this item
Full title
Epidermal growth factor receptor
Author / Creator
Publisher
BioMed Central Ltd
Journal title
BMC cancer, 2011-01, Vol.11, p.31
Language
English
Formats
Publication information
Publisher
BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Background Activating mutations of the epidermal growth factor receptor (EGFR) confer sensitivity to the tyrosine kinase inhibitors (TKi), gefitinib and erlotinib. We analysed EGFR expression, EGFR mutation status and gene expression profiles of prostate cancer (PC) to supply a rationale for EGFR targeted therapies in this disease. Methods Mutation...
Alternative Titles
Full title
Epidermal growth factor receptor
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_incontextgauss_ISR_A249342040
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_incontextgauss_ISR_A249342040
Other Identifiers
ISSN
1471-2407
E-ISSN
1471-2407
DOI
10.1186/1471-2407-11-31
How to access this item
Log in as a Library member
